Bayer (OTCMKTS:BAYRY) announced its quarterly earnings data on Wednesday. The company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.11, Morningstar.com reports. Bayer had a net margin of 10.88% and a return on equity of 18.53%.
Bayer (BAYRY) traded down $0.51 during mid-day trading on Wednesday, hitting $29.43. 520,033 shares of the stock were exchanged, compared to its average volume of 408,191. Bayer has a 52 week low of $27.74 and a 52 week high of $35.41. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.01 and a current ratio of 1.51. The firm has a market cap of $97,280.00, a P/E ratio of 22.60, a price-to-earnings-growth ratio of 2.09 and a beta of 1.14.
A number of equities research analysts recently commented on BAYRY shares. Zacks Investment Research downgraded shares of Bayer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. ValuEngine downgraded shares of Bayer from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd.
Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology.
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.